Notably, several key genes involved in TGF-β signaling, such as TGFB2, INHBA, THBS1 and SMAD3, were down-regulated in FLCN-null and mutant FLCN cells as well as in the BHD-associated renal tumors. This evidence concerns the gene SMAD3 and Renal neoplasm.